000 | 01210 a2200361 4500 | ||
---|---|---|---|
005 | 20250518081539.0 | ||
264 | 0 | _c20210208 | |
008 | 202102s 0 0 eng d | ||
022 | _a1573-2576 | ||
024 | 7 |
_a10.1007/s10753-019-01096-w _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhang, Ying | |
245 | 0 | 0 |
_aPNU-282987 Attenuates Intestinal Epithelial Barrier Dysfunction in LPS-Induced Endotoxemia. _h[electronic resource] |
260 |
_bInflammation _cApr 2020 |
||
300 |
_a417-424 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzamides _xpharmacology |
650 | 0 | 4 |
_aBridged Bicyclo Compounds _xpharmacology |
650 | 0 | 4 |
_aEndotoxemia _xchemically induced |
650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNicotinic Agonists _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
700 | 1 | _aZhou, Feng | |
700 | 1 | _aWang, Zhili | |
700 | 1 | _aLi, Zhifeng | |
700 | 1 | _aLi, Jianguo | |
773 | 0 |
_tInflammation _gvol. 43 _gno. 2 _gp. 417-424 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10753-019-01096-w _zAvailable from publisher's website |
999 |
_c30530959 _d30530959 |